Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV

Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV

Background: The high effectiveness and safety of the two-drug (2DRs) strategy using dolutegravir (DTG) plus lamivudine (3TC) have led to international guidelines recommending their use for treatment-naive HIV patients. In virologically suppressed patients, de-escalating from 3DRs to DTG plus either...

Full description

Bibliographic Details
Main Authors: Carlos Dueñas-Gutiérrez, Luis Buzón, Roberto Pedrero-Tomé, José A. Iribarren, Ignacio De los Santos, Sara De la Fuente, Guillermo Pousada, Miguel Angel Moran, Estela Moreno, Eva Ferreira, Julia Gómez, Jesús Troya
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Viruses
Subjects:
HIV/AIDS
2DR
virologically suppressed patients
Online Access:https://www.mdpi.com/1999-4915/15/4/936

Internet

https://www.mdpi.com/1999-4915/15/4/936

Similar Items